pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
PITAVASTATIN CALCIUM
PITAVASTATIN CALCIUM
no indication
ZYDUS PHARMS
Preclinical
PJ-34
Pancreatic Cancer
Tel Aviv University
Preclinical
PK-081
Parkinson's Disease
PharmaKure Ltd
Preclinical
PK-091
← prev
page 141 of 271
next →
Pain
89
Neurology
1
Neurodegenerative Diseases
PharmaKure Ltd
Preclinical
PKC Delta Inhibitors
Unspecified Cancer
Phoenicia Biosciences Inc
Phase 2
PKN-605
Atrial Fibrillation
$NVS
NOVARTIS AG
Phase 2
PL-18
Bacterial Vaginosis
Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
Preclinical
PL-265
Ocular Pain (Eye Pain)
IACTA Pharmaceuticals Inc
Preclinical
PL-7737
Obesity
$PTNT
PALATIN TECHNOLOGIES INC
Phase 2
PL-8177
Ulcerative Colitis
$PTNT
PALATIN TECHNOLOGIES INC
Preclinical
PL-8905
Obesity
$PTNT
PALATIN TECHNOLOGIES INC
Phase 3
PL-9643
Keratoconjunctivitis Sicca (Dry Eye)
$PTNT
PALATIN TECHNOLOGIES INC
Preclinical
PLA2R-CAART
Membranous Glomerulonephritis
$CABA
Cabaletta Bio, Inc.
PLERIXAFOR
PLERIXAFOR
no indication
EUGIA PHARMA
Phase 1
PLN-101095
Anal Cancer
$PLRX
PLIANT THERAPEUTICS, INC.
Phase 1
PLT-012
Hepatocellular Carcinoma
Pilatus Biosciences SA
PLUVICTO
PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN)
1 INDICATIONS AND USAGE PLUVICTO is indicated for the tre…
$NVS
NOVARTIS AG
Preclinical
PLX-300
Niemann-Pick Disease Type A (Acid Sphingomyelinase Defici…
$PLYX
Polaryx Therapeutics, Inc.
Phase 2
PM-359
Chronic Granulomatous Disease
$PRME
Prime Medicine, Inc.
Phase 1
PM-54
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Pharma Mar SA
Preclinical
PM-577
Wilson Disease
$PRME
Prime Medicine, Inc.
Phase 1
PMBCT-01
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
PeproMene Bio Inc
Phase 2
PMD-026
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Phoenix Molecular Designs
Phase 1
PMN-310
Alzheimer's Disease
$PMN
ProMIS Neurosciences Inc.
Phase 2
PMP-1606
pimecrolimus
Keratoconjunctivitis Sicca (Dry Eye)
Premark Pharma GmbH
POHERDY
POHERDY (PERTUZUMAB-DPZB)
no indication
Shanghai Henlius Biotech Inc
POLIVY
POLIVY (POLATUZUMAB VEDOTIN-PIIQ)
no indication
Genentech Inc
POLYETHYLENE GLYCOL 3350 NF
POLYETHYLENE GLYCOL 3350 NF (POLYETHYLENE GLYCOL 3350)
no indication
NUVO PHARMS INC
POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE
POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE
no indication
SOMERSET THERAPS LLC
Phase 2
PORT-77
Erythropoietic Protoporphyria
GondolaBio LLC
